4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-18-003155
Chief Medical Officer acquired 14,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Berger Mark Stanley Chief Medical Officer | 2018-03-06 | Other acquisition | +14,000 | $0.50 | $7,000 | 19,000 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Berger Mark Stanley Chief Medical Officer | 2018-03-06 | Other acquisition · Series A Warrants | +3,500 | $0.50 | $1,750 | 3,500 | D: show line 2 in the form | |||
| Berger Mark Stanley Chief Medical Officer | 2018-03-06 | Other acquisition · Series B Warrants | +10,500 | $0.50 | $5,250 | 10,500 | D: show line 3 in the form |
Loading xslF345X03/f4030618berger_actinium.xml…